Paper28293446
Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA.
Roussou E and 1 other. Eur J Rheumatol, 2017. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA. Papers, record 28293446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293446
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2442947 | Methotrexate treatment of psoriatic arthritis. | Acta Derm Venereol | 1987 | https://conductscience.org/library/papers/2442947 | PubMed |
| 2 | 23247553 | Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London. | Clin Rheumatol | 2013 | https://conductscience.org/library/papers/23247553 | PubMed |
| 3 | 1404123 | Psoriatic arthritis: clinical response and side effects to methotrexate therapy. | J Rheumatol | 1992 | https://conductscience.org/library/papers/1404123 | PubMed |
| 4 | 8295201 | Methotrexate in psoriatic polyarthritis. | J Rheumatol | 1993 | https://conductscience.org/library/papers/8295201 | PubMed |
| 5 | 8587077 | Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. | J Rheumatol | 1995 | https://conductscience.org/library/papers/8587077 | PubMed |
| 6 | 15188371 | Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. | Arthritis Rheum | 2004 | https://conductscience.org/library/papers/15188371 | PubMed |
| 7 | 16447233 | Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. | Arthritis Rheum | 2006 | https://conductscience.org/library/papers/16447233 | PubMed |
| 8 | 8575136 | Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. | Clin Exp Rheumatol | 1995 | https://conductscience.org/library/papers/8575136 | PubMed |
| 9 | 11465701 | Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. | Arthritis Rheum | 2001 | https://conductscience.org/library/papers/11465701 | PubMed |
| 10 | 19033290 | Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. | Ann Rheum Dis | 2009 | https://conductscience.org/library/papers/19033290 | PubMed |
| 11 | 7699630 | A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. | J Rheumatol | 1994 | https://conductscience.org/library/papers/7699630 | PubMed |
| 12 | 26660203 | Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/26660203 | PubMed |
| 13 | 8961906 | Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. | Arthritis Rheum | 1996 | https://conductscience.org/library/papers/8961906 | PubMed |
| 14 | 19147614 | New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). | Ann Rheum Dis | 2009 | https://conductscience.org/library/papers/19147614 | PubMed |
| 15 | 15492204 | Leflunomide in psoriasis and psoriatic arthritis: a preliminary study. | Arch Dermatol | 2004 | https://conductscience.org/library/papers/15492204 | PubMed |
| 16 | 18085735 | Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort. | J Rheumatol | 2008 | https://conductscience.org/library/papers/18085735 | PubMed |
| 17 | 21722504 | Difficulties for the detection of positive signs of sacroiliitis in spondyloarthritides by magnetic resonance imaging (MRI) in everyday clinical practice. Results from an audit circle (audit and re-audit). | Clin Exp Rheumatol | 2011 | https://conductscience.org/library/papers/21722504 | PubMed |
| 18 | 16724372 | Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. | J Rheumatol | 2006 | https://conductscience.org/library/papers/16724372 | PubMed |
| 19 | 6712754 | Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. | Arthritis Rheum | 1984 | https://conductscience.org/library/papers/6712754 | PubMed |
| 20 | 18030515 | The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. | Clin Rheumatol | 2008 | https://conductscience.org/library/papers/18030515 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30820432 | The Detergent Effect of Mesalazine Interferes with Phosphatidylcholine Binding to Mucin 2. | Inflamm Intest Dis | 2019 | https://conductscience.org/library/papers/30820432 | PubMed |
| 30207576 | Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions. | Arch Rheumatol | 2018 | https://conductscience.org/library/papers/30207576 | PubMed |
| 29616495 | Role of Methotrexate in the Management of Psoriatic Arthritis. | Drugs | 2018 | https://conductscience.org/library/papers/29616495 | PubMed |
| 28965181 | Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables. | Clin Exp Med | 2018 | https://conductscience.org/library/papers/28965181 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28293446
GET https://conductscience.org/api/papers/v1/28293446/references?page=2